Zobrazeno 1 - 10
of 282
pro vyhledávání: '"A. Ambrosetti"'
Autor:
Luana Schaad, Madison Graells, Miriam Kasztura, Elodie Schmutz, Joanna Moullin, Olivier Hugli, Jean-Bernard Daeppen, Julia Ambrosetti, Julien Ombelli, Michel Golay, Vincent Ribordy, Véronique S. Grazioli, Patrick Bodenmann
Publikováno v:
Inquiry, vol. 60, pp. 469580231159745
Background: Effective management of frequent users of emergency departments (FUED) remains challenging. Case management (CM) has shown to improve patient quality of life while reducing ED visits and associated costs. However, little data is available
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9ff261716d1cfb40bd4aaf0c8a41f7a
https://serval.unil.ch/resource/serval:BIB_6854D7444D29.P001/REF.pdf
https://serval.unil.ch/resource/serval:BIB_6854D7444D29.P001/REF.pdf
Autor:
Mirko Aldè, Stefania Barozzi, Federica Di Berardino, Gianvincenzo Zuccotti, Dario Consonni, Umberto Ambrosetti, Marina Socci, Simona Bertoli, Alberto Battezzati, Andrea Foppiani, Diego Zanetti, Lorenzo Pignataro, Giovanna Cantarella
Publikováno v:
Internal and Emergency Medicine
The relationship between SARS-CoV-2 infection and dizziness is still unclear. The aim of this study is to assess the prevalence and characteristics of dizziness and vertigo among patients with mild-to-moderate COVID-19. Patients discharged from the e
Autor:
F. Lannes, Romain Boissier, F. Michel, Pierre-Olivier Fais, Laurent Daniel, Dominique Rossi, Damien Ambrosetti, François-Xavier Deledalle, Bastien Gondran-Tellier, Mathieu Durand, Eric Lechevallier, P.-H. Savoie, Xavier Durand, Michael Baboudjian, Cyrille Bastide, Marc Andre, Gilles Karsenty
Publikováno v:
Urology. 156:185-190
Objectives To report the outcomes and feasibility of active surveillance (AS) of biopsy-proven renal oncocytomas. Methods Multicentric retrospective study (2010-2016) in 6 academic centers that included patients with biopsy-proven renal oncocytomas w
Autor:
Samantha Ferrari, L. Rigacci, Monia Capponi, Alessandro Pulsoni, Giuseppe Visani, Luca De Carolis, Pier Luigi Zinzani, Robin Foà, Paolo Falcucci, Enrico Tiacci, G. Gaidano, Eugenio Lucia, Agostino Antolino, Francesco Zaja, A. Ambrosetti, Stefano Ascani, Roberta Della Seta, Edoardo Simonetti, Natalia Frattarelli, Vincenzo Perriello, Brunangelo Falini
Publikováno v:
The New England journal of medicine. 384(19)
Hairy-cell leukemia (HCL) is a CD20+ indolent B-cell cancer in which a BRAF V600E kinase-activating mutation plays a pathogenetic role. In clinical trials involving patients with refractory or relapsed HCL, the targeting of BRAF V600E with the oral B
Autor:
Giovanna Cantarella, Diego Zanetti, Federica Di Berardino, Dario Consonni, Paola Marchisio, Umberto Ambrosetti, Mirko Aldè
Publikováno v:
Otolaryngology--Head and Neck Surgery
Objective To evaluate the role of social isolation during the lockdown due to the SARS-CoV-2 outbreak (severe acute respiratory syndrome coronavirus 2) in modifying the prevalence of otitis media with effusion (OME) and the natural history of chronic
Autor:
Mirko Aldè, Eliana Caputo, Federica Di Berardino, Umberto Ambrosetti, Stefania Barozzi, Gioia Piatti, Diego Zanetti, Lorenzo Pignataro, Giovanna Cantarella
Publikováno v:
International Journal of Pediatric Otorhinolaryngology. 164:111420
Congenital cytomegalovirus (cCMV) is the leading nongenetic cause of sensorineural hearing loss (HL). However, there are no universally accepted approaches to diagnosis, follow-up and treatment. The aim of this study was to evaluate the main characte
Autor:
Christopher Montemagno, Gilles Pagès, Renaud Grépin, Arnaud Borderie, Michael Coutts, Delphine Borchiellini, Damien Ambrosetti, Charlotte Paoli, Matthieu Durand, Jean-Christophe Bernhard, Nathalie Rioux-Leclercq, Olivia Rastoin, Maeva Dufies
Publikováno v:
BJU International
BJU International, 2022, 129 (1), pp.80-92. ⟨10.1111/bju.15506⟩
BJU International, Wiley, 2021, ⟨10.1111/bju.15506⟩
BJU International, 2022, 129 (1), pp.80-92. ⟨10.1111/bju.15506⟩
BJU International, Wiley, 2021, ⟨10.1111/bju.15506⟩
International audience; Objectives: To investigate the role of cancer-associated fibroblasts (CAFs) in clear cell renal cell carcinoma (ccRCC) with respect to tumour aggressiveness, metastasis development, and resistance to anti-angiogenic therapy (v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99a5b132ebf2bd7f4db2126fc13952f8
https://hal.science/hal-03476907/document
https://hal.science/hal-03476907/document
Autor:
Alessandro D. Genazzani, Christian Battipaglia, Tabatha Petrillo, Nicola Piacquadio, Fedora Ambrosetti, Melania Arnesano, Elisa Semprini, Alessandra Sponzilli, Veronica Tomatis, Tommaso Simoncini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4132131dd418f71e94fc067dc9e65bab
https://hdl.handle.net/11380/1288141
https://hdl.handle.net/11380/1288141
Autor:
Hervé Quintens, Mélanie Guyot, Florence Dupré, Jérôme Durivault, Jean-François Roussel, Damien Ambrosetti, Gilles Pagès, Renaud Grépin, Aurore Dumond
Publikováno v:
Theranostics
Metastatic clear cell renal cell carcinomas (mRCC) over-express the vascular endothelial growth factor (VEGF). Hence, the anti-VEGF antibody bevacizumab/Avastin (BVZ) combined with interferon alpha (IFN) was approved for the treatment of mRCC. Howeve